These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 38004334)
1. An Integrative Approach to the Current Treatment of HIV-Associated Neurocognitive Disorders and the Implementation of Leukemia Inhibitor Factor as a Mediator of Neurocognitive Preservation. De Freitas-Suarez A; Espinosa-Ponce N; Alvarez-Roger N; Cabrera-Suarez AI; Jiménez-Jordán G; Vega-Roman R; Inyushin M; Alves JM Life (Basel); 2023 Nov; 13(11):. PubMed ID: 38004334 [TBL] [Abstract][Full Text] [Related]
2. Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review. Borrajo A; Pérez-Rodríguez D; Fernández-Pereira C; Prieto-González JM; Agís-Balboa RC Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762667 [TBL] [Abstract][Full Text] [Related]
3. Interrogating the impact of combination antiretroviral therapies on HIV-associated neurocognitive disorders. Sharma I HIV Med; 2021 Oct; 22(9):783-790. PubMed ID: 34291558 [TBL] [Abstract][Full Text] [Related]
5. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221 [TBL] [Abstract][Full Text] [Related]
6. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection. Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875 [TBL] [Abstract][Full Text] [Related]
7. Beneficial and Adverse Effects of cART Affect Neurocognitive Function in HIV-1 Infection: Balancing Viral Suppression against Neuronal Stress and Injury. Yuan NY; Kaul M J Neuroimmune Pharmacol; 2021 Mar; 16(1):90-112. PubMed ID: 31385157 [TBL] [Abstract][Full Text] [Related]
8. Natural Bioactives as Potential Therapeutic Modalities Against NeuroAIDS. Ahmed M; Iqubal A; Baboota S; Ali J Curr Top Med Chem; 2021; 21(12):1052-1066. PubMed ID: 33845745 [TBL] [Abstract][Full Text] [Related]
9. Unravelling the triad of neuroinvasion, neurodissemination, and neuroinflammation of human immunodeficiency virus type 1 in the central nervous system. Calado M; Ferreira R; Pires D; Santos-Costa Q; Anes E; Brites D; Azevedo-Pereira JM Rev Med Virol; 2024 May; 34(3):e2534. PubMed ID: 38588024 [TBL] [Abstract][Full Text] [Related]
10. Induction of Heme Oxygenase-1 Deficiency and Associated Glutamate-Mediated Neurotoxicity Is a Highly Conserved HIV Phenotype of Chronic Macrophage Infection That Is Resistant to Antiretroviral Therapy. Gill AJ; Kovacsics CE; Vance PJ; Collman RG; Kolson DL J Virol; 2015 Oct; 89(20):10656-67. PubMed ID: 26269184 [TBL] [Abstract][Full Text] [Related]